Hyperuricaemia: more than just a cause of gout?

被引:109
作者
Katsiki, Niki [1 ]
Karagiannis, Asterios [1 ]
Athyros, Vasilios G. [1 ]
Mikhailidis, Dimitri P. [2 ,3 ]
机构
[1] Aristotle Univ Thessaloniki, Hippocrat Hosp, Propedeut Dept Internal Med 2, GR-54006 Thessaloniki, Greece
[2] UCL, Sch Med, Dept Clin Biochem Vasc Dis Prevent Clin, London NW3 2QG, England
[3] UCL, Sch Med, Dept Surg, London NW3 2QG, England
关键词
cardiovascular disease; gout; metabolic syndrome; renal disease; uric acid; vascular risk; SERUM URIC-ACID; PERIPHERAL ARTERIAL-DISEASE; CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; INTIMA-MEDIA THICKNESS; FATTY LIVER-DISEASE; TYPE-2; DIABETES-MELLITUS; LOW-GRADE INFLAMMATION; METABOLIC SYNDROME; RISK-FACTORS;
D O I
10.2459/JCM.0b013e3283595adc
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Traditionally, serum uric acid (SUA) has been implicated in acute gouty arthritis or chronic gouty arthropathy. However, SUA also plays a role in other pathological conditions especially in cardiovascular (CV), metabolic and renal disease. This narrative review considers the significant associations of SUA with kidney function, several CV risk factors and vascular diseases, supporting the concept of assessing hyperuricaemia for reasons other than just gout. Several drugs that reduce CV risk also decrease SUA levels, further improving vascular risk. Therefore, selecting SUA-lowering drugs to treat high-risk patients may prove beneficial in terms of reducing CV risk.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 141 条
[1]
[Anonymous], COCHRANE DATABASE SY
[2]
[Anonymous], INT J CARDIOL
[3]
Effect of fenofibrate on kidney function:: A 6-week randomized crossover trial in healthy people [J].
Ansquer, Jean-Claude ;
Dalton, R. Neil ;
Causse, Elisabeth ;
Crimet, Dominique ;
Le Malicot, Karine ;
Foucher, Christelle .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (06) :904-913
[4]
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome - A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study [J].
Athyros, Vasilios G. ;
Mikhailidis, Dimitri P. ;
Liberopoulos, Evangelos N. ;
Kakafika, Anna I. ;
Karagiannis, Asterios ;
Papageorgiou, Athanasios A. ;
Tziomalos, Konstantinos ;
Ganotakis, Emmanuel S. ;
Elisaf, Moses .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (01) :118-127
[5]
Athyros VG, 2011, ARCH MED SCI, V7, P984, DOI [10.5114/AOMS.2011.26610, 10.5114/aoms.2011.26610]
[6]
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study [J].
Athyros, Vassilios G. ;
Karagiannis, Asterios ;
Ganotakis, Emmanouel S. ;
Paletas, Konstantinos ;
Nicolaou, Vassilios ;
Bacharoudis, George ;
Tziomalos, Konstantinos ;
Alexandrides, Theodore ;
Liberopoulos, Evangelos N. ;
Mikhailidis, Dimitri P. .
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (08) :1659-1668
[7]
Pathogenesis and treatment of kidney disease and hypertension - Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study [J].
Athyros, VG ;
Elisaf, M ;
Papageorgiou, AA ;
Symeonidis, AN ;
Pehlivanidis, AN ;
Bouloukos, VI ;
Milionis, HJ ;
Mikhailidis, DP .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) :589-599
[8]
Serum uric acid level and risk for peripheral arterial disease: Analysis of data from the multiple risk factor intervention trial [J].
Baker, Joshua F. ;
Schumacher, H. Ralph ;
Krishnan, Eswar .
ANGIOLOGY, 2007, 58 (04) :450-457
[9]
Association between Serum Uric Acid Levels and Diabetes Mellitus [J].
Bandaru, Pavani ;
Shankar, Anoop .
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2011, 2011
[10]
Uric Acid as a Factor in the Metabolic Syndrome [J].
Borges, Rodolfo Leao ;
Ribeiro, Artur Beltrame ;
Zanella, Maria Teresa ;
Batista, Marcelo Costa .
CURRENT HYPERTENSION REPORTS, 2010, 12 (02) :113-119